tiprankstipranks
Molecular Partners (MLLCF)
:MLLCF
US Market

Molecular Partners AG (MLLCF) Income Statement

Compare
11 Followers

Molecular Partners AG Income Statement

Last quarter (Q4 2023), Molecular Partners AG's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Molecular Partners AG's net income was $―. See Molecular Partners AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 7.04M$ 189.54M$ 9.33M$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 2.42M$ -1.20M$ -1.20M$ 568.00K$ 381.00K
EBITDA
$ ―$ 120.24M$ -61.22M$ -59.59M$ -33.74M
Operating Income
$ -60.26M$ 115.93M$ -63.84M$ -58.33M$ -36.66M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -61.98M$ 123.17M$ -55.78M$ -62.76M$ -36.29M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Molecular Partners AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis